4-Desmethoxy Omeprazole
CAS No. 110374-16-8
4-Desmethoxy Omeprazole ( —— )
Catalog No. M23305 CAS No. 110374-16-8
4-Desmethoxy Omeprazole is the active metabolite of Omeprazole. Omeprazole is a proton pump inhibitor (PPI).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 272 | In Stock |
|
10MG | 408 | In Stock |
|
25MG | 672 | In Stock |
|
50MG | 945 | In Stock |
|
100MG | 1278 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Desmethoxy Omeprazole
-
NoteResearch use only, not for human use.
-
Brief Description4-Desmethoxy Omeprazole is the active metabolite of Omeprazole. Omeprazole is a proton pump inhibitor (PPI).
-
Description4-Desmethoxy Omeprazole is the active metabolite of Omeprazole. Omeprazole is a proton pump inhibitor (PPI). Omeprazole shows competitive inhibition of CYP2C19 activity (Ki: 2 to 6 μM).
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorDrug Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number110374-16-8
-
Formula Weight315.4
-
Molecular FormulaC16H17N3O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC1=CC(=C(N=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li XQ, et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos. 2004 Aug;32(8):821-7.
molnova catalog
related products
-
2-Methylacetophenone
2-Methylacetophenone is an endogenous metabolite.
-
Acetamide
Acetamide is found in red beetrootis used primarily as a solvent and a plasticizer.
-
L-(-)-Arabitol
L-Arabinitol is a potential biomarker for the comsuption of the food products such as sweet potato deerberry moth bean and is also associated with Alzheimer's disease and ribose-5-phosphate isomerase deficiency.